
Valitse etikettisi
näkyy suoraan injektiopullossaARA-290
Healing
- Lähetetään Saksasta
Tilaus
- DHL seurannalla
- Huomaamaton pakkaus
Yhdellä silmäyksellä
ARA-290 lukuina
Tietopankkimme keskeiset luvut.
Koko tietopankkiartikkeli- Class
- EPO-derived peptidenon-hematopoietic
- Half-life
- short
- Use
- Subcutaneousin mg
- Sizes
- 10 to 16 mg2 sizes in the shop
What studies show
The source in the lexicon- Heij, Brines et al., Molecular Medicine, 2012
Tuotteelle ARA-290 ei ole vielä laboratorioanalyysia. Äänestä sitäTestauta itse, me maksamme puoletKaikki laboratorioanalyysit
Tietoa
Kaikki aiheesta ARA-290
Tarkemmat tiedot tulossa pian.
Annostelu
Ladataan annostelutietoja …
Tilaa samalla
Mitä tarvitset sen kanssa
Bakteriostaattinen vesi lisätään ostoskoriisi automaattisesti. Ruiskut ja pyyhkeet yhdellä napsautuksella.
Insuliiniruiskut
10 kpl · 5.50 €
Alkoholipyyhkeet
50 kpl · 10 €
Kuinka paljon vettä?
Ruiskun yksiköt injektiopullosi koolle.
Avaa laskuri →What is ARA-290?
A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.
What do the sarcoidosis studies show?
In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.
What about type 2 diabetes?
In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.
Does ARA-290 help with eye diseases?
In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.
Does ARA-290 affect mood?
In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.
Which side effects are known?
No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.
Liittyvät
Samankaltaiset tuotteet
BPC-157
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
4 kokoa
Laboratoriotestattu
= alkaen 5.2 €/injektiopullo
TB-500 (Thymosin B4)
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 18.8 €/injektiopullo
TB-500 FRAG
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
1 koko
= 24.8 €/injektiopullo
BPC + TB Blend
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 24.8 €/injektiopullo
ARA-290